Summary:
This week on The Genetics Podcast, Patrick is joined by Lisa Gurry, Chief Business Officer of GeneDx. They discuss her path from two decades at Microsoft to leading one of the most influential genomics companies, GeneDx’s mission to deliver the fastest rare disease diagnoses, and how large-scale data, newborn screening, and AI are shaping the future of precision medicine.
Show Notes:
0:00 Intro to The Genetics Podcast
01:00 Welcome to Lisa and her career path leading to joining GeneDx
03:27 The core components of GeneDx and how they drive early rare disease diagnosis
06:18 Insights from early genomic newborn screening pilots
11:37 The clinical impact and economic benefits of newborn genomic screening
14:27 How GeneDx combines data, AI, and clinical expertise to improve genomic interpretation
17:44 A vision for a lifelong genomic passport and how it could guide care across every stage of life
20:42 How GeneDx Infinity is unlocking new therapeutic possibilities in genetically linked autism
22:48 How advocacy communities guide patient identification and connect families to opportunities
26:00 Lessons from 23 years at Microsoft that Lisa now applies to leading GeneDx
30:39 How Truveta emerged from the COVID crisis to build a shared-data platform for population-scale health insights
32:13 What excites Lisa most about leading GeneDx and where she sees the biggest opportunities ahead
34:59 Closing remarks
Please consider rating and reviewing us on your chosen podcast listening platform!
https://drive.google.com/file/d/1Bp2_wVNSzntTs_zuoizU8bX1dvao4jfj/view?usp=share_link
